Cited by 106Phytochemicals and Medicinal PlantsMedicinal Plants and Bioactive CompoundsSports Performance and Training

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis

Open access

Abstract

Ashwagandha (Withania somnifera) is considered a potent adaptogen and anti-stress agent that could have some potential to improve physical performance. This preferred reporting items for systematic reviews and meta-analyses (PRISMA)-based comprehensive systematic review and Bayesian meta-analysis aimed to evaluate clinical trials up to 2020 from PubMed, ScienceDirect, and Google Scholar databases regarding the effect of Ashwagandha supplementation on physical performance in healthy individuals. Besides implementing estimation statistics analysis, we developed Bayesian hierarchical models for a pre-specified subgroup meta-analysis on strength/power, cardiorespiratory fitness and fatigue/recovery variables. A total of 13 studies met the requirements of this systematic review, although only 12 were included in the quantitative analysis. A low-to-moderate overall risk of bias of the trials included in this study was detected. All Bayesian hierarchical models converged to a target distribution (Ȓ = 1) for both meta-analytic effect size (μ) and between-study standard deviation (τ). The meta-analytic approaches of the included studies revealed that Ashwagandha supplementation was more efficacious than placebo for improving variables related to physical performance in healthy men and female. In fact, the Bayesian models showed that future interventions might be at least in some way beneficial on the analyzed outcomes considering the 95% credible intervals for the meta-analytic effect size. Several practical applications and future directions are discussed, although more comparable studies are needed in exercise training, and athletic populations are needed to derive a more stable estimate of the true underlying effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jfmk6010020

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Conclusive evidence from rigorous, methodologically sound, well-designed, validated, and replicated trials does not exist for the indications for which ashwagandha is used.

    “Nonetheless, conclusive evidence from rigorous, methodologically sound, well-designed, validated, and replicated trials does not exist for the aforementioned indications.11–13”

    From Ashwagandha-induced liver injury—A case series from India and literature review (2023) · cites this paper as [12]

    The Discussion (4.1) says the small number of studies means pooled effects should be interpreted cautiously and further research is needed to confirm ashwagandha’s effects on physical performance. The Conclusions (5) nevertheless report benefits over placebo. The paper does not establish that conclusive evidence is lacking for all the other indications implied by “aforementioned indications,” or that rigorous, validated trials do not exist. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 59

  1. Gupta, 2015, Rasayanas: Ayurvedische Behandlung von altersbedingten Erkrankungen, Z. Komplementärmedizin, 7, 22, 10.1055/s-0035-1570133 · DOI
  2. Mishra, 2000, Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review, Altern. Med. Rev., 5, 334
  3. Singh, N., Bhalla, M., De Jager, P., and Gilca, M. (2011). An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda. Afr. J. Tradit. Complement. Altern. Med., 8. · DOI · Paper page
  4. Mirjalili, 2009, Steroidal lactones from Withania somnifera, an ancient plant for novel medicine, Molecules, 14, 2373, 10.3390/molecules14072373 · DOI
  5. Tripathi, 2019, Berry transcriptome: Insights into a novel resource to understand development dependent secondary metabolism in Withania somnifera (Ashwagandha), Physiol. Plant., 168, 148, 10.1111/ppl.12943 · DOI
  6. Nile, 2019, Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities, Food Chem. Toxicol., 132, 110659, 10.1016/j.fct.2019.110659 · DOI
  7. Trivedi, 2017, Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy, Chem. Biodivers., 14, e1600280, 10.1002/cbdv.201600280 · DOI
  8. Jayaprakasam, 2003, Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves, Life Sci., 74, 125, 10.1016/j.lfs.2003.07.007 · DOI
  9. Kaileh, 2007, Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity, J. Biol. Chem., 282, 4253, 10.1074/jbc.M606728200 · DOI
  10. Pratte, 2014, An Alternative Treatment for Anxiety: A Systematic Review of Human Trial Results Reported for the Ayurvedic Herb Ashwagandha (Withania somnifera), J. Altern. Complement. Med., 20, 901, 10.1089/acm.2014.0177 · DOI
  11. Durg, 2018, Withania somnifera (Indian ginseng) in male infertility: An evidence-based systematic review and meta-analysis, Phytomedicine, 50, 247, 10.1016/j.phymed.2017.11.011 · DOI
  12. Zomorrodi, 2018, Effects of Withania somnifera on Reproductive System: A Systematic Review of the Available Evidence, Biomed. Res. Int., 2018, 1
  13. Durg, 2020, Withania somnifera (Indian ginseng) in diabetes mellitus: A systematic review and meta-analysis of scientific evidence from experimental research to clinical application, Phytother. Res., 34, 1041, 10.1002/ptr.6589 · DOI
  14. Durg, 2015, Withania somnifera(Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: A systematic review and meta-analysis, J. Pharm. Pharmacol., 67, 879, 10.1111/jphp.12398 · DOI
  15. Pérez-Gómez, J., Villafaina, S., Adsuar, J.C., Merellano-Navarro, E., and Collado-Mateo, D. (2020). Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis. Nutrients, 12. · DOI
  16. Wankhede, 2015, Examining the effect of Withania somnifera supplementation on muscle strength and recovery: A randomized controlled trial, J. Int. Soc. Sports Nutr., 12, 43, 10.1186/s12970-015-0104-9 · DOI · Paper page
  17. Estarli, 2016, Ítems de referencia para publicar Protocolos de Revisiones Sistemáticas y Metaanálisis: Declaración PRISMA-P 2015, Rev. Esp. Nutr. Hum. Diet., 20, 148, 10.14306/renhyd.20.2.223 · DOI
  18. Cousineau, 2018, A review of effect sizes and their confidence intervals, Part I: The Cohen’s d family, Quant. Methods Psychol., 14, 242, 10.20982/tqmp.14.4.p242 · DOI
  19. Borenstein, M., Hedges, L.V., Higgins, J.P., and Rothstein, H.R. (2011). Introduction to Meta-Analysis, John Wiley & Sons.
  20. Cumming, G. (2012). Understanding the New Statistics: Effect Sizes, Confidence Intervals, and Meta-Analysis, Routledge. · DOI
  21. Sandhu, 2010, Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults, Int. J. Ayurveda Res., 1, 144, 10.4103/0974-7788.72485 · DOI
  22. Raut, 2012, Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers, J. Ayurveda Integr. Med., 3, 111, 10.4103/0975-9476.100168 · DOI
  23. Shenoy, 2012, Effects of eight-week supplementation of Ashwagandha on cardiorespiratory endurance in elite Indian cyclists, J. Ayurveda Integr. Med., 3, 209, 10.4103/0975-9476.104444 · DOI
  24. Malik, 2013, Effect of Ashwagandha (Withania somnifera) root powder supplementation on the VO2 max. and hemoglobin in hockey players, Int. J. Behav. Soc. Mov. Sci., 2, 91
  25. Kuchewar, 2014, Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers, AYU (Int. Q. J. Res. Ayurveda), 35, 46, 10.4103/0974-8520.141919 · DOI
  26. Pingali, 2014, Effect of standardized aqueous extract of Withania somniferaon tests of cognitive and psychomotor performance in healthy human participants, Pharmacogn. Res., 6, 12, 10.4103/0974-8490.122912 · DOI
  27. Salve, J., Pate, S., Debnath, K., and Langade, D. (2019). Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus, 11. · DOI · Paper page
  28. Lopresti, 2019, An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract, Medicine, 98, e17186, 10.1097/MD.0000000000017186 · DOI · Paper page
  29. Deshpande, 2020, A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults, Sleep Med., 72, 28, 10.1016/j.sleep.2020.03.012 · DOI · Paper page
  30. Powers, 2008, Exercise-induced oxidative stress: Cellular mechanisms and impact on muscle force production, Physiol. Rev., 88, 1243, 10.1152/physrev.00031.2007 · DOI · Paper page
  31. Ferreira, 2008, Muscle-derived ROS and thiol regulation in muscle fatigue, J. Appl Physiol., 104, 853, 10.1152/japplphysiol.00953.2007 · DOI
  32. McKenna, 2006, N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans, J. Physiol, 576, 279, 10.1113/jphysiol.2006.115352 · DOI
  33. Medved, 2004, Effects of intravenous N-acetylcysteine infusion on time to fatigue and potassium regulation during prolonged cycling exercise, J. Appl Physiol., 96, 211, 10.1152/japplphysiol.00458.2003 · DOI
  34. Medved, 2004, N-acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance-trained individuals, J. Appl Physiol., 97, 1477, 10.1152/japplphysiol.00371.2004 · DOI
  35. Shanks, N., Greek, R., and Greek, J. (2009). Are animal models predictive for humans?. Philos. Ethicsand Humanit. Med., 4. · DOI · Paper page
  36. Palliyaguru, 2016, Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms, Free Radic. Biol. Med., 101, 116, 10.1016/j.freeradbiomed.2016.10.003 · DOI
  37. Yan, 2018, Withaferin A inhibits apoptosis via activated Akt-mediated inhibition of oxidative stress, Life Sci., 211, 91, 10.1016/j.lfs.2018.09.020 · DOI
  38. Reuland, 2013, Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress, Free Radic. Biol. Med., 56, 102, 10.1016/j.freeradbiomed.2012.11.016 · DOI
  39. Hybertson, B.M., Gao, B., Bose, S., and McCord, J.M. (2019). Phytochemical Combination PB125 Activates the Nrf2 Pathway and Induces Cellular Protection against Oxidative Injury. Antioxidants, 8. · DOI
  40. Velmurugan, 2009, Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim, Free Radic. Biol. Med., 46, 430, 10.1016/j.freeradbiomed.2008.10.050 · DOI
  41. Bakkar, 2010, NF-kappaB signaling: A tale of two pathways in skeletal myogenesis, Physiol. Rev., 90, 495, 10.1152/physrev.00040.2009 · DOI
  42. Ichikawa, 2006, Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression, Mol. Cancer, 5, 1434, 10.1158/1535-7163.MCT-06-0096 · DOI
  43. Ravindranath, 2006, Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: Potential application to choroidal neovascularization, Investig. Ophthalmol. Vis. Sci., 47, 4138, 10.1167/iovs.05-1452 · DOI
  44. Schumacher, 2002, Hematological indices in elite cyclists, Scand. J. Med. Sci. Sports, 12, 301, 10.1034/j.1600-0838.2002.10112.x · DOI
  45. Borges, 2012, Haematological changes in elite kayakers during a training season, Appl. Physiol. Nutr. Metab., 37, 1140, 10.1139/h2012-102 · DOI
  46. Rietjens, 2002, Red blood cell profile of elite olympic distance triathletes. A three-year follow-up, Int. J. Sports Med., 23, 391, 10.1055/s-2002-33736 · DOI
  47. Saunders, 2013, Relationship between changes in haemoglobin mass and maximal oxygen uptake after hypoxic exposure, Br. J. Sports Med., 47, i26, 10.1136/bjsports-2013-092841 · DOI
  48. Calbet, 2006, Importance of hemoglobin concentration to exercise: Acute manipulations, Respir. Physiol. Neurobiol., 151, 132, 10.1016/j.resp.2006.01.014 · DOI
  49. Mountjoy, 2018, IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update, Br. J. Sports Med., 52, 687, 10.1136/bjsports-2018-099193 · DOI · Paper page
  50. Lopresti, 2019, A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males, Am. J. Men’s Health, 13, 155798831983598, 10.1177/1557988319835985 · DOI
  51. Gabrielsen, 2017, Iron and Testosterone: Interplay and Clinical Implications, Curr. Sex. Health Rep., 9, 5, 10.1007/s11930-017-0097-2 · DOI
  52. Langade, D., Kanchi, S., Salve, J., Debnath, K., and Ambegaokar, D. (2019). Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus, 11. · DOI · Paper page
  53. Ramakanth, 2016, A randomized, double blind placebo controlled study of efficacy and tolerability of Withaina somnifera extracts in knee joint pain, J. Ayurveda Integr. Med., 7, 151, 10.1016/j.jaim.2016.05.003 · DOI
  54. Sterling, 2012, Allostasis: A model of predictive regulation, Physiol. Behav., 106, 5, 10.1016/j.physbeh.2011.06.004 · DOI · Paper page
  55. Sangwan, 2004, Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha), Curr. Sci., 86, 461
  56. Tomar, 2019, A validated HPTLC method for the simultaneous quantifications of three phenolic acids and three withanolides from Withania somnifera plants and its herbal products, J. Chromatogr. B, 1124, 154, 10.1016/j.jchromb.2019.06.009 · DOI
  57. Choudhary, 2016, Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract, J. Evid. Based Complement. Altern. Med., 22, 96, 10.1177/2156587216641830 · DOI
  58. Choudhary, 2017, Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions, J. Diet. Suppl., 14, 599, 10.1080/19390211.2017.1284970 · DOI · Paper page
  59. Kelgane, S.B., Salve, J., Sampara, P., and Debnath, K. (2020). Efficacy and Tolerability of Ashwagandha Root Extract in the Elderly for Improvement of General Well-being and Sleep: A Prospective, Randomized, Double-blind, Placebo-controlled Study. Cureus, 12. · DOI

Cited by

Sorted by citations

Metadata

Authors
Bonilla, D. A., Moreno, Y., Gho, C., Petro, J. L., Odriozola-Martínez, A., & Kreider, R. B.
Affiliations
  • University of the Basque Country (ES)
  • Universidad Distrital Francisco José de Caldas (CO)
  • Research Division, Dynamical Business & Science Society—DBSS International SAS, Bogotá 110861, Colombia
  • Universidad de Córdoba (CO)
  • Texas A&M University (US)
Corresponding author
Bonilla, Diego A.
Venue
Journal of Functional Morphology and Kinesiology
Publisher
MDPI AG
Published
2021-02-11
Volume
6
Issue
1
Pages
20
ISSN
2411-5142 (ISSN-L)
OpenAlex
W3126875939
Cited by
106
References
13
Citations by year
2026: 30 · 2025: 24 · 2024: 22 · 2023: 19 · 2022: 10 · 2021: 1
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • Journal of Functional Morphology and Kinesiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Bioactive Compounds
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Sports Performance and Training
Keywords
Withania somnifera, physical performance, adaptogens, anti-stress agents, strength and power, cardiorespiratory fitness, fatigue, recovery, dietary supplementation, healthy individuals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review